Grow Group Plc said it acquired a major medical cannabis production facility in Spain in a move that will provide the company with control of the entire medical cannabis supply chain, from farm to pharmacy.
Under the deal, Grow will buy 100% of Sanoid Isolates, whose high-tech facilities in the South of Spain will allow the group to produce a range of cannabis Active Pharmaceutical Ingredients and cannabis medicines in-house.
“This will ensure patients globally can benefit from the highest quality medicines at accessible prices,” Grow said in a statement.
The company, which accounts for around 20% of the UK cannabis medicine market and currently provides over 1,200 people in the UK with cannabis medicines, said it raised over GBP3.2mln through a crowdfunding to help it cement its UK position and fuel international expansion.
